FDA Expands Indication of Regional Analgesic to Reduce Postsurgical Pain Without Opioids
Bupivacaine liposome injectable suspension was shown to reduce opioid use after surgery and significantly improve pain.
Source: pharmacytimes.com
Dave Stack News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dave Stack. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dave Stack Today - Breaking & Trending Today
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an...
Source: marketscreener.com
Pacira BioSciences Inc (PCRX) Reports Q3 2023 Financial Results
Net Income of $10.9 Million Despite Slight Decrease in Total Revenues
Source: yahoo.com
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 -- Pacira BioSciences, Inc. , the industry leader in its commitment...
Source: marketscreener.com
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Q2, 2023 Pacira BioSciences Inc. Earnings Conference Call. At this time, all participants are in listen-only mode.
Source: insidermonkey.com